Expect POTUS, Congress to respond to excessive industry pricing and to focus more on opioid abuse.
- Supreme Court May Preserve EDTX Grip on Patent Cases
- Wilmer Grows Civil Rights Practice, Agency GCs Find Homes, Gorelick Explains Trump-Team Clients
- Hacker Tries Extortion Plot vs. Apple, but Co. Says it Is Not Harmed; Here's What To Do
- Here Are The Hill Lawyers Behind Obamacare Repeal Efforts
- Manafort, Willing to Talk, Hires Top Wilmer Partner
- Patent Lawyers, Anticipating a Shake-Up, Warily Watch SCOTUS
U.S. Supreme Court nominee Judge Neil Gorsuch emerged unscathed from two very long days of questioning by the Senate Judiciary Committee but his biggest hurdle may be yet to come.
The U.S. Court of Appeals for the Fourth Circuit agreed Thursday to expedite a challenge to President Donald Trump’s travel ban executive order, setting oral arguments in the case for May 8 at the court in Richmond.
Health insurer Anthem Inc. pressed Friday to salvage its proposed $54 billion acquisition of Cigna Corp., arguing before a Washington federal appeals court that the deal would drive down costs for consumers.
Fending off questions about his lucrative law practice and potential conflicts of interest, Jay Clayton, the Sullivan & Cromwell partner who was nominated to lead the U.S. Securities and Exchange Commission, on Thursday defended his private sector experience as an asset and said he was "committed to showing no favoritism to anyone in this position."
During arguments Monday in the closely watched TC Heartland v. Kraft Foods Group Brands, several justices seemed resistant to shaking up the status quo, which allows broad latitude in where patent cases may be filed.
The U.S. Supreme Court is being asked to reassert a previous interpretation of the rules, which limited patent suits to the districts where companies are incorporated.